ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 86371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 86371; 2) Community: the network communities that were significantly associated with the response to NSC 86371; 3) Molecule: the relationships between components within communities and NSC 86371; 4) MDR: the compounds that were significantly associated with the NSC 86371.

NSC Compound Enrichment Correlation
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.0220292715546634 0.42283232
NSC 727012 (2S,3S)-3,4-Epoxy-2-(3-methoxy-5-methyl-1-naphthoyloxy)-3-methylbutanamide 0.0220292715546634 0.33412522
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0220292715546634 0.50169181
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0220292715546634 0.44824522
NSC 730294 Null 0.0220292715546634 0.24000487
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0220292715546634 0.50367034
NSC 742146 Bisarylpurine 0.0220292715546634 0.39175807
NSC 746248 Null 0.0220292715546634 0.18549606
NSC 749909 4-methoxy-2,6-bis[hydroxy(methyl)amino]-1,3,5-triazine 0.0220292715546634 0.094579054
NSC 755417 Null 0.0220292715546634 0.50828831
Total:139  Current:80    [First] [Prev] [Next] [Last]